Reusable Iron‐Copper Catalyzed Cross‐Coupling of Primary Amides with Aryl and Alkyl Halides: Access to N ‐Arylamides as Potential Antibacterial and Anticancer Agents
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202403649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Keya Roy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Engineering Science and Technology, Shibpur, Botanic Garden, Howrah, 711103, India. Hauptthemen laut MEDLINE: Copper, Anti-Bacterial Agents, Antineoplastic Agents, Amides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 162 Literaturangaben.
Abstract (Originalsprache)
We present, for the first time, an efficient ligand‐free iron‐copper catalyzed cross‐coupling reaction involving a variety of aryl, heteroaryl halides (including chlorides, bromides, and iodides), and alkyl bromides with diverse aryl and aliphatic primary amides, conducted under solvent‐minimized conditions. This economically competitive protocol successfully yielded the corresponding cross‐coupling products, N ‐arylamides and N ‐alkylamides, in good to excellent yields with broad substrate scope (65 examples) and tolerance to several sensitive functionalities (including heterocycles). No conventional work‐up is required for this protocol, and the developed method is applicable for gram‐scale synthesis. Notably, the catalyst is inexpensive, environmentally friendly, and can be reused at least four times with minimal loss of catalytic activity. A series of experiments, including X‐ray photoelectron spectroscopy (XPS), UV spectroscopy, cyclic voltammetry (CV), electron paramagnetic resonance (EPR), and X‐ray diffraction (XRD) were conducted to identify the oxidation state of active catalytic species and radical clock experiment was performed using a radical probe to investigate the reaction mechanism. Furthermore, we evaluated the antibacterial and anticancer properties of selected synthesized products ( 3 ii , 3 xii , and 3 xxxx ) in‐vitro . The results indicated that the prepared compounds exhibited promising antibacterial and anticancer activities (MTT and Molecular Docking).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Engineering Science and Technology, Shibpur, Botanic Garden, Howrah, 711103, India.
- Department of Chemistry and Chemical Biology, Indian Institute of Technology (ISM), Dhanbad, Jharkhand, 826004, India.
- Center of Healthcare Science and Technology, Indian Institute of Engineering Science and Technology, Shibpur, Botanic Garden, Howrah, 711103, India.
ORCID-Profile: Laksmikanta Adak
Zitieren
APA
Roy, K., Saha, A., Saha, B., Banerjee, S., Mukhopadhyay, C. D., Sahu, S. K., & Adak, L. (2025). Reusable Iron‐Copper Catalyzed Cross‐Coupling of Primary Amides with Aryl and Alkyl Halides: Access to N ‐Arylamides as Potential Antibacterial and Anticancer Agents. Chemistry – A European Journal. https://doi.org/10.1002/chem.202403649
Vancouver
Roy K, Saha A, Saha B, Banerjee S, Mukhopadhyay CD, Sahu SK, et al. Reusable Iron‐Copper Catalyzed Cross‐Coupling of Primary Amides with Aryl and Alkyl Halides: Access to N ‐Arylamides as Potential Antibacterial and Anticancer Agents. Chemistry – A European Journal. 2025. doi:10.1002/chem.202403649
BibTeX
@article{Roy2025,
author = {Roy, Keya and Saha, Anay and Saha, Bijay and Banerjee, Subhrajyoti and Mukhopadhyay, Chitrangada Das and Sahu, Sumanta Kumar and Adak, Laksmikanta},
title = {Reusable Iron‐Copper Catalyzed Cross‐Coupling of Primary Amides with Aryl and Alkyl Halides: Access to N ‐Arylamides as Potential Antibacterial and Anticancer Agents},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202403649}
}
EUVIMED